Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Recalled July 17, 2013 · FDA recall D-708-2013 · Lowlite Investments, Inc.
Hazard
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes · FDA Class II
Units
3
Sold at
Nationwide and PR
Description
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Product
Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Manufacturer(s)
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →